{
  "id": 14466122,
  "title": "Three-Year Real-World Study Compares Burosumab Treatment with Oral Phosphate and Active Vitamin D in Adults with XLH",
  "url": "https://urgent.news/2026/10/14/three-year-real-world-study-compares-burosumab-treatment-with-oral",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-14T13:56:42.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/three-year-real-world-study-compares-burosumab-treatment-with-oral-phosphate-and-active-vitamin-d-in-adults-with-xlh"
  },
  "original_language": "en",
  "account": null,
  "summary": "Publication in the Journal of Bone and Mineral Research offers new insight into the long-term XLH treatment experience PRINCETON, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced the publication of three-year real-world findings from an interim analysis of the […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}